Innate Pharma SA Files 6-K Report
Ticker: IPHYF · Form: 6-K · Filed: May 28, 2024 · CIK: 1598599
| Field | Detail |
|---|---|
| Company | Innate Pharma SA (IPHYF) |
| Form Type | 6-K |
| Filed Date | May 28, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-private-issuer, biotechnology
TL;DR
Innate Pharma SA filed a 6-K on 5/28/24, standard foreign issuer report.
AI Summary
On May 28, 2024, Innate Pharma SA filed a Form 6-K, reporting its status as a foreign private issuer. The filing includes an index of exhibits, but the specific content of these exhibits is not detailed in the provided text. Innate Pharma SA is a biotechnology company based in Marseille, France, specializing in biological products.
Why It Matters
This filing indicates ongoing reporting compliance for Innate Pharma SA, a company involved in the biotechnology sector, which is crucial for investors tracking its regulatory adherence.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign private issuer and does not contain new financial or operational information that would typically alter risk.
Key Players & Entities
- Innate Pharma SA (company) — Registrant
- May 28, 2024 (date) — Filing date
- 001-39084 (other) — Commission File Number
- Marseille, France (location) — Company headquarters
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed with the SEC when they are obligated to disclose or distribute information to their security holders pursuant to the laws of their home country.
What is Innate Pharma SA's primary business?
Innate Pharma SA is involved in Biological Products (no diagnostic substances), as indicated by its SIC code.
Where is Innate Pharma SA located?
Innate Pharma SA is located at 117 Avenue de Luminy, BP 30191, 13009 Marseille, France.
What is the Commission File Number for Innate Pharma SA?
The Commission File Number for Innate Pharma SA is 001-39084.
Does Innate Pharma SA file annual reports under Form 20-F?
Yes, Innate Pharma SA indicates it files annual reports under cover of Form 20-F.
Filing Stats: 206 words · 1 min read · ~1 pages · Grade level 10.3 · Accepted 2024-05-28 06:03:49
Filing Documents
- a6k-iphx240528.htm (6-K) — 10KB
- exhibit991-240528.htm (EX-99.1) — 14KB
- 0001598599-24-000042.txt ( ) — 24KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. INNATE PHARMA S.A. Date May 28, 2024 By s HERVE BRAILLY Name Herv Brailly Title Chairman of the Executive Board and Chief Executive officer